Researchers in the UK have shown that a single dose
Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to
CAL20.C SARS-CoV-2 variant skyrocketing in California evades host immune response
The effect of different neutralizing antibodies, both vaccine-elicited and from
Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants
Researchers in the United States have described a novel rapid
SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model
The emergence of new strains of the severe acute respiratory
Study of children hospitalized with COVID-19 shows 2% mortality
The current coronavirus disease 2019 (COVID-19) pandemic caused by the
Novel SARS-CoV-2 vaccine utilizes recombinant spike protein with PIKA adjuvant
The primary aim of any vaccine is to stimulate immune
How does the SARS-CoV-2 E484K mutation increase viral fitness?
How do mutations benefit severe acute respiratory syndrome coronavirus 2
A glycan controls how SARS-CoV-2’s spike protein opens, study finds
Using simulations, a team of researchers in the U.S. found
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential